Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-19-008081
Filing Date
2019-02-14
Accepted
2019-02-14 16:01:45
Documents
2
Group Members
JEREMY C. GREEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv513373_sc13ga.htm SC 13G/A 66083
2 EXHIBIT 99.1 tv513373_ex99-1.htm EX-99.1 4655
  Complete submission text file 0001144204-19-008081.txt   72254
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Subject) CIK: 0000855654 (see all company filings)

EIN.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-40774 | Film No.: 19605862
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

EIN.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A